County Durham technology company Kromek has secured £8.8m in new orders and expects to report full-year revenue growth and profit before tax in line with market expectations, capping a year of strong commercial and operational progress across its two core divisions.

The AIM-listed business, which develops radiation detection and bio-detection technologies for healthcare, security and defence markets, said both its Advanced Imaging and CBRN Detection divisions delivered further progress during the year ended 30 April 2026.

Results for the full year are expected to reflect increased revenue in the CBRN Detection division and good underlying growth in Advanced Imaging, excluding the previously announced exceptional contribution linked to its enablement agreement with Siemens Healthineers.

A significant proportion of the £8.8m in new orders secured across both divisions during the second half was delivered before year end, alongside continued execution of previously secured contracts.

Dr Arnab Basu, CEO of Kromek, said: "This reflects a year of steady operational delivery and continued commercial progress across both of our divisions. In the second half of the year, alongside the execution of previously secured contracts, the Group won new orders totalling £8.8m, a significant portion of which was delivered before year end."

The CBRN Detection division delivered year-on-year revenue growth, supported by continued global demand despite delays in some governmental contracts progressing to procurement stage. In Advanced Imaging, the company reported good underlying growth through progress on long-term SPECT contracts and expansion of its photon-counting CT customer base.

Kromek also navigated supply chain disruption linked to shifting international trade relationships and wider geopolitical tensions, although the company said the impact was primarily related to the timing of fulfilments rather than underlying demand.

Dr Basu added: "Importantly, we were able to significantly mitigate that disruption through the successful delivery of a major new order from an existing customer in the second half.

"The performance reinforces our confidence in the value of Kromek's technology and the critical role our solutions play as customers move toward the build and commercialisation of next-generation photon counting CT and SPECT scanners."

Headquartered in Sedgefield, Kromek develops advanced radiation detection technologies used across medical imaging, homeland security, defence and civil nuclear markets, with manufacturing operations in the UK and US.

The company said it ended the year with continued momentum and remains focused on delivering growth across both divisions ahead of its full-year results announcement in September 2026.

Dr Basu said: "Overall, this has been a year that demonstrates the resilience of our business model, the strength of our customer relationships, and the growing relevance of our technology in mission-critical applications."

Market consensus expectations for FY26 stand at revenues of £27.2m and profit before tax of £2.15m.